2013-024 Resolution of the 12th Board of Directors of Jianfeng Group
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviations: Jianfeng Group Number: pro 2013-024
Zhejiang Jianfeng Group Co., Ltd. 12th Board of Directors Resolution Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
On August 2, 2013, Zhejiang Jianfeng Group Co., Ltd. issued the convening of the 8th Board of Directors by fax, e-mail, telephone , and personal delivery. The notice of the 12 th meeting, this meeting was held by a combination of on-site and communication. On August 14, 2013, the on-site meeting was held as scheduled in the conference room of Zhejiang Jinhua Jianfeng Building. Five people attended the on-site meeting. Four foreign directors Huang Sujian, Deng Mingran, Liu Jiajian and Zhang Yuyou voted by fax. The on-site meeting was presided over by Chairman Jiang Xiaomeng, and supervisors and senior managers of Company attended the meeting as nonvoting delegates, in accordance with the relevant regulations of the Company Law and the Articles of Association of the Company , the resolution made is legal and valid. After deliberation and voting, the following resolution was adopted:
1. 2013 semi-annual report After deliberation and voting, the board of directors adopted the 2013 semi-annual report of the company. Voting result: 9 votes in favor, 0 votes against and 0 abstentions. 2. Proposal on Jianfeng Pharmaceutical to Set up a Joint Venture to Cooperate in Developing New Drugs After deliberation and voting, the board of directors passed the proposal, agreeing that Jianfeng Pharmaceutical should contribute 2090
yuan in monetary installments and Shanghai Hansheng Biotechnology Co., Ltd. should contribute 1710 yuan in patented technology intellectual property rights to set up a joint venture, carry out research, development and operation of new anti-tumor drugs (YLK ). It is also agreed that Jianfeng Pharmaceutical will pay Shanghai Hansheng Biotechnology Co., Ltd. 400 yuan in cash compensation for early research and development in installments .
Voting result: 9 votes in favor, 0 votes against, 0 abstentions. After deliberation and voting on the 3.'s related party transaction proposal on the acquisition of the equity of peak cement, the board of directors passed the related party transaction proposal, agreeing that the company should acquire the 1.34 equity of Zhejiang peak cement co., ltd.
held by Jinhua peak union investment co., ltd. at a price of of 8.71 million yuan. Jiang Xiaomeng, Du Zihong and Yu Jianhong, directors of Guan of the company, avoided voting on the bill.
voting result: 6 votes in favor, 0 votes against, 0 votes abstained. For details, please refer to the Announcement of Related Transactions on the Acquisition of Equity Interest in Peak Cement (P.91 2013-025 ).
hereby announces
August 16, 2013
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
More information
On the afternoon of June 9, Peak Cable Company organized all employees to learn fire fighting knowledge and conducted fire fighting and emergency escape drills. Since June, the subordinate enterprises of the company have organized training, learning and drills related to production safety according to their own characteristics and combined with the actual work. Safety production month series of activities carried out in an orderly manner.
2022
06-13
Spike Postdoctoral Research Papers on International Frontier Journals
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat, a hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease" were published in the internationally renowned academic journal "Frontiers in Pharmacology. This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
2022
06-01
Daye Peak QC Achievements Won the Third Prize of Huangshi City
On May 7, Huangshi City Quality Strong City Working Committee organized a 2022 QC Results Conference. The QC project of "Technical Transformation of Ore Limestone Batching System" of Daye Peak Cement Company won the third prize.
2022
06-01
On April 28, Dalian Commodity Exchange held an online working meeting to announce the results of the 2021 excellent delivery warehouse and delivery warehouse excellent futures personnel selection, peak international trading company won the 2021 "excellent designated delivery warehouse" title, futures commissioner Ruan Weihang won the "excellent futures personnel" title.
2022
06-01
Cranberry extract combination identification detection method won the invention patent
After cranberry extract products were included in the "Zhejiang Province Key High-tech Product Development Project Plan" in 2021, Jianfeng Health Technology Company recently obtained an invention patent for the identification and detection method of cranberry extract. This new combined identification and detection method developed by Jianfeng Health identifies whether catechin or procyanidin B2 is added in cranberry extract by thin layer analysis, and then detects the unique A- type procyanidin and its chromatographic distribution in cranberry extract by high performance liquid chromatography, so as to improve the accuracy of product judgment. The identification method has the characteristics of accurate results and short detection time, which is of great significance to standardize the cranberry extract market and promote the healthy development of the industry, and has been unanimously recognized by peers.
2022
05-20
Daye Peak Manufacturing Department Won the Title of "Worker Pioneer" in Hubei Province
A few days ago, the manufacturing department of Daye Peak Cement Company was awarded the title of "Worker Pioneer" by the Hubei Provincial Federation of Trade Unions. Daye Jianfeng Manufacturing Department not only continued to actively explore and achieved good results in energy saving and consumption reduction, technological transformation, product quality process control, and economic responsibility system to guide management, but also improved Daye Jianfeng's overall operation level and won Huangshi City The seventh "Mayor Quality Award" created conditions and was fully affirmed by government departments at all levels.
2022
05-20
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page